Control of Toll-like Receptor 7 Expression Is Essential to Restrict Autoimmunity and Dendritic Cell Proliferation
Top Cited Papers
Open Access
- 1 November 2007
- Vol. 27 (5), 801-810
- https://doi.org/10.1016/j.immuni.2007.09.009
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Allergy and Infectious Diseases
This publication has 41 references indexed in Scilit:
- A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosusNature Genetics, 2006
- U1 small nuclear ribonucleoprotein immune complexes induce type I interferon in plasmacytoid dendritic cells through TLR7Blood, 2006
- Systemic lupus erythematosusBMJ, 2006
- TLR9/MyD88 signaling is required for class switching to pathogenic IgG2a and 2b autoantibodies in SLEThe Journal of Experimental Medicine, 2006
- Toll‐like receptor 9 signaling protects against murine lupusArthritis & Rheumatism, 2005
- Immune stimulation mediated by autoantigen binding sites within small nuclear RNAs involves Toll-like receptors 7 and 8The Journal of Experimental Medicine, 2005
- Control of B-cell responses by Toll-like receptorsNature, 2005
- RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagementThe Journal of Experimental Medicine, 2005
- Chromatin–IgG complexes activate B cells by dual engagement of IgM and Toll-like receptorsNature, 2002
- Spontaneous Autoimmune Disease in FcγRIIB-Deficient Mice Results from Strain-Specific EpistasisImmunity, 2000